Location: Home page > Research&Achievement

Introduction of Scientific Research

Under the support of municipal party committee, municipal government, Nanjing university and Jiangsu and Nanjing Commission of Health, Nanjing Drum Tower hospital adheres to innovation, increase the platform construction, speed up the discipline developing and personnel training, high-level scientific and technological achievements have been achieved, to promote the development of medical technology and achieve fruitful results. It has made positive contributions to the construction of healthy Nanjing, innovative city and "double first-class" of Nanjing University.

Historic breakthroughs were made in the approval of research projects, which strongly supported the rapid development of disciplines. In the past ten years, the hospital has received 2992 scientific research projects which are funded by the government, with a total scientific research fund of 1.08 billion yuan. 33 major and key projects were funded by the Ministry of Science and Technology and the National Foundation of Science and Technology, and 656 projects won the National Natural Science Foundation of China. Among them, it has led one national Science and Technology Innovation 2030- "Brain Science and Brain-like Research" major project, four national Key research and development programs, one National Major New Drug Special project, 21 national Key projects, key national cooperation projects and major instrument projects. In 2021, 83 projects of National Natural Science Foundation of China were funded, creating a new high, and 4 key projects of National Natural Science Foundation of China ranked first in the province.

High-level scientific and technological achievements enhance the international influence of disciplines. In the past ten years, the hospital has published 10,528 academic papers, 3,546 SCI papers, and 182 high-quality papers with IF above 10. A number of representative articles have been published in Immunity, Nature Medicine, J Clin Invest, J Hepatol, J Natl Cancer Inst, PNAS, Cell Res, and Lancet Diabetes Endo and other internationally influential high quality journals. In 2020, It ranked 22nd in Chinese scientific papers, 35th in SCI papers, and 21st in China Excellence International Scientific Papers. In 2022, it ranked 9th among medical institutions in Nature INDEX.

High-level talents lead high-quality researches. After the development of the 13th Five-Year Plan, Qiu Yong, director of the Department of Orthopedics of our hospital was awarded "Foreign Academician of the French National Academy of Surgery", Zhu Dalong, director of the department of endocrinology, served as the chairman of the Chinese Medical Association Diabetes Branch, and Sun Haixiang, director of reproductive Medicine, served as the chairman designate of the Chinese Medical Association Reproductive Medicine Branch. Hu Yali, Jiang Qing, Zou Xiaoping, Xu Yun and other directors respectively serve as the vice chairmen of the corresponding Chinese Medical Association branch. At present, our hospital has 2 national outstanding young scholars, 4 national outstanding young scholars, 3 national talents, 19 chairmen and alternate chairmen of Jiangsu Medical Association branch, and 3 outstanding medical talents of Jiangsu Province. At the same time, our hospital has introduced 46 high-level talents from famous foreign universities, Nanjing University, Southeast University, Nanjing Medical University. These introduced talents and the high-level discipline leaders of our hospital form the core research team , which greatly improves the research level of all disciplines.

Original scientific and technological achievements drive technological innovation. In the past 10 years, it has won 480 scientific and technological achievement awards, including 1 second prize of National Technological Invention Award, 6 second prizes of Ministry of Education, 16 projects won Chinese Medical Science and Technology Awards, and 11 first prizes of provincial Science and Technology Progress. A large number of research achievements reflect the research level of Drum Tower Hospital, highlighting the research characteristics of our hospital. Clinical studies on stem cells take the lead in our country, "Key technological innovation and clinical application of allogeneic mesenchymal stem cells in the treatment of refractory lupus erythematosus" won the second prize of national Technical Invention in 2019.